References
- Timmer-Bosscha, H., Mulder, N.H. and de Vries, E.G. Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br. J. Cancer. 66:227-238, 1992 https://doi.org/10.1038/bjc.1992.249
- Goldstein, R.S. and Mayor, G.H. Minireview. The nephrotoxicity of cisplatin. Life Sci. 32:685-690, 1983 https://doi.org/10.1016/0024-3205(83)90299-0
- Safirstein, R., Winston, J., Goldstein, M., Moel, D., Dikman, S. and Guttenplan, J. Cisplatin nephrotoxicity. Am. J. Kidney Dis. 8:356-367, 1986 https://doi.org/10.1016/S0272-6386(86)80111-1
- Eastman, A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 34:155-166, 1987 https://doi.org/10.1016/0163-7258(87)90009-X
- Siddik, Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279, 2003 https://doi.org/10.1038/sj.onc.1206933
- Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M. and Lord, J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256:34-41, 2000 https://doi.org/10.1006/excr.2000.4836
- Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.E., Karandikar, M., Berman, K. and Cobb, M.H. Mitogen- activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153-183, 2001 https://doi.org/10.1210/er.22.2.153
- Cobb, M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71:479-500, 1999 https://doi.org/10.1016/S0079-6107(98)00056-X
- Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995 https://doi.org/10.1126/science.270.5240.1326
- Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252, 2000 https://doi.org/10.1016/S0092-8674(00)00116-1
- Lee, S.J., Saiki, I., Hayakawa, Y., Nunome, S., Yamada, H., Kim, S.H. Antimetastatic and immunomodulating properties of a new herbal prescription, Bojung-bangam-tang. Int. Immunopharmacol. 3:147-157, 2000 https://doi.org/10.1016/S1567-5769(02)00091-7
- Hengartner, M.O. The biochemistry of apoptosis. Nature 407:770-776, 2000 https://doi.org/10.1038/35037710
- Ito, Y., Pandey, P., Sporn, M.B., Datta, R., Kharbanda, S. and Kufe, D. The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol. Pharmacol. 59:1094-1099, 2001 https://doi.org/10.1124/mol.59.5.1094
- Ito, Y., Pandey, P., Place, A., Sporn, M.B., Gribble, G.W., Honda, T., Kharbanda, S. and Kufe D. The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. Cell Growth. Differ. 11:261-267, 2000
- Guyton, K,Z,, Liu, Y., Gorospe, M., Xu, Q. and Holbrook, N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 271:4138-4142, 1996 https://doi.org/10.1074/jbc.271.8.4138
- Wang, X., Martindale, J.L., Liu, Y. and Holbrook, N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333:291-300, 1998 https://doi.org/10.1042/bj3330291
- DeHaan, R.D., Yazlovitskaya, E.M., Persons, D.L. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase. Cancer Chemother. Pharmacol. 48:383-388, 2001 https://doi.org/10.1007/s002800100318
- Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H. and Mercola, D., Murata, Y. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem. 274:31648-31654, 1999 https://doi.org/10.1074/jbc.274.44.31648
- Persons, D.L., Yazlovitskaya, E.M. and Pelling, J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 275:35778-357785, 2000 https://doi.org/10.1074/jbc.M004267200
- Nowak, G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J. Biol. Chem. 277:43377-43388, 2002 https://doi.org/10.1074/jbc.M206373200
- Sanchez-Perez, I., Murguia, J.R. and Perona, R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16:533-540, 1998 https://doi.org/10.1038/sj.onc.1201578
- Kim, Y.K., Kim, H.J., Kwon, C.H., Kim, J.H., Woo, J.S., Jung, J.S. and Kim, J.M. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J. Appl. Toxicol. 25:374-382, 2005 https://doi.org/10.1002/jat.1081
- Wang, X., Martindale, J.L. and Holbrook, N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J .Biol. Chem. 275:39435-39443, 2000 https://doi.org/10.1074/jbc.M004583200
- Fan, M. and Chambers, T.C. Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist. Updat. 4:253-267, 2001 https://doi.org/10.1054/drup.2001.0214
- Zanke, B.W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L.A., Zon, L., Kyriakis, J., Liu, F.F. and Woodgett, J.R. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol. 6:606-613, 1996 https://doi.org/10.1016/S0960-9822(02)00547-X
- Sanchez-Perez, I. and Perona, R. Lack of c-Jun activity increases survival to cisplatin. FEBS Lett. 453:151-158 https://doi.org/10.1016/S0014-5793(99)00690-0
- Mishima, K., Baba, A., Matsuo, M., Itoh, Y. and Oishi, R. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radic. Biol. Med. 40:1564-1577, 2006 https://doi.org/10.1016/j.freeradbiomed.2005.12.025
- Brozovic, A., Fritz, G., Christmann, M., Zisowsky, J., Jaehde, U., Osmak, M. and Kaina, B. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int. J. Cancer 112:974-985, 2004 https://doi.org/10.1002/ijc.20522
- Guadagno, T,M, and Ferrell, J.E. Jr. Requirement for MAPK activation for normal mitotic progression in Xenopus egg extracts. Science 282:1312-1315, 1998 https://doi.org/10.1126/science.282.5392.1312
- Wright, J.H., Munar, E., Jameson, D.R., Andreassen, P.R., Margolis, R.L., Seger, R. and Krebs, E.G. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. USA. 96:11335-11340, 1999
- Bulavin, D.V., Higashimoto, Y., Popoff, I.J., Gaarde, W.A., Basrur, V., Potapova, O., Appella, E. and Fornace, A.J. Jr. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411:102-107, 2001 https://doi.org/10.1038/35075107
- Wang, X., McGowan, C.H., Zhao, M., He, L., Downey, J.S., Fearns, C., Wang, Y., Huang, S. and Han, J. Involvement of the MKK6-p38gamma cascade in gamma-radiation- induced cell cycle arrest. Mol. Cell Biol. 20:4543-4552, 2000 https://doi.org/10.1128/MCB.20.13.4543-4552.2000